Superantigens and SARS-CoV-2.

Pathogens · 2022 · PMC9026686 · PMID 35456065

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

While SARS-CoV-2 may not be canonically superantigenic in vitro, the in vivo consequences may be significant due to other danger and death signals [ 113 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.